Global Oncolytic Virus Therapy Market Competitors, Segment Types and Downstream Applications Research Report 2025

Research Summary

Oncolytic virus therapy, also known as virotherapy, is a type of cancer treatment that utilizes genetically engineered or naturally occurring viruses to selectively target and destroy cancer cells. The viruses used in oncolytic virus therapy are designed to replicate within cancer cells, causing their death while leaving healthy cells unharmed. This therapy takes advantage of the natural ability of certain viruses to infect and replicate within cells. Oncolytic viruses can be modified to enhance their tumor targeting, safety, and anticancer effects. When administered to patients, these viruses selectively infect and replicate within cancer cells, leading to tumor cell lysis and the release of tumor-associated antigens. This process stimulates an immune response, promoting the recognition and destruction of both infected cancer cells and non-infected cancer cells. Oncolytic virus therapy has shown promise in preclinical and clinical trials for various types of cancer and may be used as a standalone treatment or in combination with other cancer therapies, such as chemotherapy, radiation, or immunotherapy. The field of oncolytic virus therapy continues to evolve, with ongoing research and clinical trials aiming to optimize the therapeutic potential and broaden the utility of this innovative treatment approach.

According to WENKH research statistics, the global Oncolytic Virus Therapy market sales revenue reached  Million USD in 2024 and is expected to reach  Million USD by 2032, with a compound annual growth rate (CAGR) of  % from 2025 to 2032. Among them, the China Oncolytic Virus Therapy market has experienced rapid changes in recent years, reaching  Million USD in 2024, accounting for approximately  % of the global market share. It is projected to reach  Million USD by 2032.

The global Oncolytic Virus Therapy market is highly competitive, with key market players including Amgen, Oncolytics Biotech, Viralytics, Oncolys BioPharma, Transgene SA, Targovax, PsiOxus Therapeutics, SillaJenBiotherapeutics, Genelux Corporation, Sorrento Therapeutics, Lokon Pharma, Cold Genesys, TILT Biotherapeutics, Vyriad, etc. This report categorizes the competitive landscape of the global Oncolytic Virus Therapy market into three tiers based on annual revenue, with the top three market players holding approximately  % of the total market share.

This report provides an in-depth analysis of the global Oncolytic Virus Therapy market, including market size, price trends, market status and future development prospects. It particularly focuses on the market share, product characteristics, pricing, sales revenue, and gross profit margin of major players in the global Oncolytic Virus Therapy industry. Additionally, this report provides an in-depth analysis of the market status and future development trends of different product segments of Oncolytic Virus Therapy and their downstream application fields.

In terms of data, this report includes a comprehensive time-series dataset. The historical data spans from 2020 to 2024, providing a solid foundation for analyzing past market trends. The year 2025 is used as a base year to accurately assess the current market landscape. Forecast data covers the period from 2026 to 2032, utilizing scientific analysis methods and models to offer forward-looking predictions and insights into the market's future development. This provides valuable reference information for industry participants and stakeholders.

The report covers countries including United States, China, Germany, Japan, France, South Korea, United Kingdom, India, Italy, Brazil, Mexico, Indonesia, Vietnam and South Africa. It particularly focuses on the sales revenue of Oncolytic Virus Therapy in these countries, as well as the product segmentation and downstream application market size of each country. The report provides an in-depth analysis of the regional distribution and future development trends of the Oncolytic Virus Therapy market. By considering local policies, this report evaluates the market prospects of Oncolytic Virus Therapy in each country, aiming to help companies gain a comprehensive understanding of the industry characteristics and development potential in different regions, optimize regional business layout, and develop precise market strategies to achieve global development goals.

This report places a strong emphasis on data quality and reliability, utilizing diverse and extensive data sources to ensure the accuracy and validity of the information presented. Primary data collection involves multiple channels, including in-depth interviews with senior executives, industry experts, supply chain stakeholders, and end consumers. These interviews provide key insights into corporate strategic planning, industry policy interpretation, supply chain dynamics, and end-user experiences. Secondary data sources cover a wide range of authoritative statistics from government agencies, customs databases, industry associations, third-party paid databases, brokerage research reports, academic research findings, corporate annual reports, financial statements, real-time news updates, and relevant information from international organizations. These data sources serve as a solid foundation for verification and analysis.

Companies Covered

Amgen

Oncolytics Biotech

Viralytics

Oncolys BioPharma

Transgene SA

Targovax

PsiOxus Therapeutics

SillaJenBiotherapeutics

Genelux Corporation

Sorrento Therapeutics

Lokon Pharma

Cold Genesys

TILT Biotherapeutics

Vyriad

Product Segment

HSV-based Oncolytic Viruses

Adenoviruses-based Oncolytic Viruses

Vaccinia Virus-based Oncolytic Viruses

Vesicular Stomatitis Virus-based Oncolytic Viruses

Newcastle Disease Virus-based Oncolytic Viruses

Product Application

Melanoma

Prostate Cancer

Breast Cancer

Ovarian Cancer

Others

Chapter Scope

Chapter 1: Product Statistical Scope, Product Segmentation Types and Downstream Applications, Overall Market Size, Current Status and Development Prospects

Chapter 2: Global Oncolytic Virus Therapy Industry Chain Analysis

Chapter 3: Global Oncolytic Virus Therapy Industry Environment Analysis and Porter's Five Forces Analysis

Chapter 4: Analysis of the Competitive Landscape of Major Companies in the Global Oncolytic Virus Therapy Market (Market Share, Product Revenue Comparison, Tier Division, Corporate Expansion and M&A Trends)

Chapter 5: Analysis of Global Major Companies (Company Profiles, Product Specifications and Features, Product Revenue and Product Gross Profit Margin)

Chapter 6: Global Oncolytic Virus Therapy Market Analysis by Countries, Product Segment and Downstream Application

Chapter 7: United States Oncolytic Virus Therapy Market Size, Product Segment, Downstream Application Analysis

Chapter 8: China Oncolytic Virus Therapy Market Size, Product Segment, Downstream Application Analysis

Chapter 9: Germany Oncolytic Virus Therapy Market Size, Product Segment, Downstream Application Analysis

Chapter 10: Japan Oncolytic Virus Therapy Market Size, Product Segment, Downstream Application Analysis

Chapter 11: France Oncolytic Virus Therapy Market Size, Product Segment, Downstream Application Analysis

Chapter 12: South Korea Oncolytic Virus Therapy Market Size, Product Segment, Downstream Application Analysis

Chapter 13: United Kingdom Oncolytic Virus Therapy Market Size, Product Segment, Downstream Application Analysis

Chapter 14: India Oncolytic Virus Therapy Market Size, Product Segment, Downstream Application Analysis

Chapter 15: Italy Oncolytic Virus Therapy Market Size, Product Segment, Downstream Application Analysis

Chapter 16: Brazil Oncolytic Virus Therapy Market Size, Product Segment, Downstream Application Analysis

Chapter 17: Mexico Oncolytic Virus Therapy Market Size, Product Segment, Downstream Application Analysis

Chapter 18: Indonesia Oncolytic Virus Therapy Market Size, Product Segment, Downstream Application Analysis

Chapter 19: Vietnam Oncolytic Virus Therapy Market Size, Product Segment, Downstream Application Analysis

Chapter 20: South Africa Oncolytic Virus Therapy Market Size, Product Segment, Downstream Application Analysis

Chapter 21: Research Conclusion

Chapter 22: Methodology and Data Source

Purpose and Value of the Report

Market Trend Insights: Analyze industry trends, market dynamics, and future growth potential to help companies forecast changes and develop strategic plans.

Competitive Landscape Analysis: Understand key players' revenue segmentation, strategies, market share, and business models to guide competitive decisions.

Investment Decision Support: Provide feasibility analysis through market size, growth rate, demand trends, and potential risks for informed investment decisions.

Target Customer and Demand Analysis: Examine consumer behavior, purchasing preferences, and pain points to optimize products and improve market penetration.

Policy and Regulatory Insights: Interpret relevant industry policies to ensure compliance and mitigate regulatory risks.

Business Model Optimization: Offer data-driven suggestions for enhancing business models and improving profitability.